Coalition Of Cancer Cooperative Groups
- Assets
- $18.4m
- Revenue
- $10.8m
- Investments
- $10.0k
- Employees
- 70
- Location
- Philadelphia, PA
- Founding
- 03/1998
- Data as of
- 06/2022
- EIN
- 23-2935628
Organization Overview
Coalition Of Cancer Cooperative Groups is located in Philadelphia, PA. The organization was established in 1998. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 06/2022, Coalition Of Cancer Cooperative Groups employed 70 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Coalition Of Cancer Cooperative Groups is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Coalition Of Cancer Cooperative Groups generated $10.8m in total revenue. The organization has seen a slow decline revenue. Over the past 6 years, revenues have fallen by an average of (0.1%) each year. All expenses for the organization totaled $9.6m during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (1.6%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE PURPOSE OF THE COALITION IS TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR CANCER PATIENTS BY INCREASING THE PARTICIPATION IN CANCER CLINICAL TRIALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FEDERAL GRANTS - THE COALITION, THROUGH ITS FEDERAL FUNDING, SUPPORTS THE EFFORTS OF THE ECOG-ACRIN GROUP CO-CHAIR'S OFFICE THROUGH SUCH SERVICES AS CONTRACTING, GRANT AND FISCAL OVERSIGHT, LEGAL COUNSEL, COMMUNICATION, AND GENERAL ADMINISTRATION. FURTHERMORE, THE COALITION ASSISTS IN EXPEDITING THE DEVELOPMENT AND CONDUCT OF ECOG-ACRIN STUDIES, ASSISTS WITH THE DEVELOPMENT AND DISSEMINATION OF EDUCATIONAL MATERIALS FOR ONCOLOGISTS AND PATIENTS, WORKS TO IMPROVE PATIENT ACCRUAL TO ECOG-ACRIN TRIALS, AND COORDINATES THE ECOG-ACRIN SEMI-ANNUAL GROUP MEETINGS.
INTERNET BASED PUBLIC SERVICE PROGRAMS PASS-THROUGH FUNDS TO NCI FUNDED NATIONAL CANCER CLINICAL TRIALS COOPERATIVE GROUPS AND SITES PAYMENTS OF ALLOCATED SHARED COSTS
CANCER TRIALS SUPPORT UNIT (CTSU) - UNDER A SUBCONTRACT WITH WESTAT, INC. (ROCKVILLE, MD) THE COALITION PROVIDES PROFESSIONAL AND SUPPORT STAFF TO OPERATE AND MANAGE THE REGULATORY SUPPORT SYSTEM AND OTHER KEY FUNCTIONS OF THE CTSU (A MAJOR CLINICAL TRIAL PROGRAM OF THE NATIONAL CANCER INSTITUTE (NCI, U.S. DEPT OF HEALTH AND HUMAN SERVICES), UNDER WESTAT'S PRIME CONTRACT WITH NCI, NO. HHSN261200622012C, ADB NO. N02-CM-62212.
PRIVATE FOUNDATION GRANTS - THROUGH A GRANT PROVIDED BY THE BREAST CANCER RESEARCH FOUNDATION, THE COALITION PROVIDES ASSISTANCE TO ECOG INVESTIGATORS WHO ARE CONDUCTING A STUDY ON LATE RELAPSE BREAST CANCER BY SERVING AS THE PRIME GRANTEE WHO IS RESPONSIBLE FOR LIAISING WITH THE GRANTOR, MONITORING GRANT PROGRESS AND SUBMITTING BI-ANNUAL REPORTS, DISSEMINATING GRANT FUNDING TO SUBCONTRACTORS FOR VARIOUS ASPECTS OF THE STUDY, AND DEVELOPING AND DISSEMINATING MATERIALS TO BOLSTER ACCRUAL TO THE STUDY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Peter O'dwyer President | OfficerTrustee | 2 | $0 |
Charles Blanke Director | Trustee | $0 | |
Monica Bertagnolli Director | Trustee | $0 | |
Doug Hawkins Director | Trustee | $0 | |
Robert Mannel Director | Trustee | $0 | |
Mitchell Schnall Director | Trustee | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $2,697,681 |
| All other contributions, gifts, grants, and similar amounts not included above | $190,000 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,887,681 |
| Total Program Service Revenue | $7,863,857 |
| Investment income | $59 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $10,751,597 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $5,299,650 |
| Pension plan accruals and contributions | $162,414 |
| Other employee benefits | $1,282,852 |
| Payroll taxes | $424,631 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $2,233 |
| Fees for services: Accounting | $24,400 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $268,554 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $1,073,937 |
| Travel | $3,877 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $3,718 |
| Interest | -$5,499 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $78,049 |
| Insurance | $56,778 |
| All other expenses | $65,868 |
| Total functional expenses | $9,561,314 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $8,189 |
| Savings and temporary cash investments | $5,764,758 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $11,973,188 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $25,379 |
| Net Land, buildings, and equipment | $583,806 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $10,000 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $50,000 |
| Total assets | $18,415,320 |
| Accounts payable and accrued expenses | $9,458,181 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $205,438 |
| Total liabilities | $9,663,619 |
| Net assets without donor restrictions | $8,524,751 |
| Net assets with donor restrictions | $226,950 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $18,415,320 |